Literature DB >> 15804675

Playing hide-and-seek with the tobacco industry.

Eric M LeGresley1, Monique E Muggli, Richard D Hurt.   

Abstract

Despite many peer-reviewed works that draw on tobacco industry documents that have now been made public, questions remain about how complete a picture has emerged. We present a conceptual framework that identifies and evaluates tobacco industry efforts to conceal information. Widespread document destruction like that in recent litigation in Australia is just one of more than a dozen tobacco industry efforts to prevent access, or at least timely access, to documents. Industry efforts range from small, locally employed initiatives to company-wide tactics. Some efforts, such as using "oral only" procedures, scrambling telephone lines, or involving lawyers in scientific projects, are preemptive. Others seek to deal with already existing documents by invoking bogus claims of legal privilege, stipulating "read then destroy" for memos, and rewriting problematic memos. That evidence of concealment has, in fact, been found in tobacco company archives attests to the futility of attempting to control the flow of millions of pieces of paper among tens of thousands of employees. However, researchers have yet to reveal the full story: We know of the industry's failures in concealing information, but not its successes. The industry's objective is not destruction of information per se, but prevention of public disclosure of that information. Exposing the tobacco industry's many approaches to concealment provides greater insight into companies' intentions and potential means for stripping away that concealment.

Entities:  

Mesh:

Year:  2005        PMID: 15804675     DOI: 10.1080/14622200412331328529

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  26 in total

1.  Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco's perspectives.

Authors:  Mariaelena Gonzalez; Lawrence W Green; Stanton A Glantz
Journal:  Tob Control       Date:  2011-06-02       Impact factor: 7.552

2.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Open doorway to truth: legacy of the Minnesota tobacco trial.

Authors:  Richard D Hurt; Jon O Ebbert; Monique E Muggli; Nikki J Lockhart; Channing R Robertson
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

4.  Enticing the New Lad: Masculinity as a Product of Consumption in Tobacco Industry-Developed Lifestyle Magazines.

Authors:  Daniel K Cortese; Pamela M Ling
Journal:  Men Masc       Date:  2011-04

5.  Tobacco company strategies to identify and promote the benefits of nicotine.

Authors:  Pamela M Ling; Stanton A Glantz
Journal:  Tob Control       Date:  2018-08-09       Impact factor: 7.552

6.  Tobacco industry marketing to low socioeconomic status women in the U.S.A.

Authors:  Cati G Brown-Johnson; Lucinda J England; Stanton A Glantz; Pamela M Ling
Journal:  Tob Control       Date:  2014-01-21       Impact factor: 7.552

7.  When tobacco targets direct democracy.

Authors:  Elizabeth Laposata; Allison P Kennedy; Stanton A Glantz
Journal:  J Health Polit Policy Law       Date:  2014-03-06       Impact factor: 2.265

8.  Tobacco Industry Promotions and Pricing After Tax Increases: An Analysis of Internal Industry Documents.

Authors:  Dorie E Apollonio; Stanton A Glantz
Journal:  Nicotine Tob Res       Date:  2020-05-26       Impact factor: 4.244

9.  Philip Morris's health information web site appears responsible but undermines public health.

Authors:  Elizabeth A Smith; Ruth E Malone
Journal:  Public Health Nurs       Date:  2008 Nov-Dec       Impact factor: 1.462

10.  The strategic targeting of females by transnational tobacco companies in South Korea following trade liberalization.

Authors:  Kelley Lee; Carrie Carpenter; Chaitanya Challa; Sungkyu Lee; Gregory N Connolly; Howard K Koh
Journal:  Global Health       Date:  2009-01-30       Impact factor: 4.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.